- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05061173
Comparison of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults
Compare the Effects of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Azad Jamu Kashmir
-
Kotli, Azad Jamu Kashmir, Pakistan, 11100
- District Headquarter Hospital - kotli
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hypertensive with BP greater than 140/90 mmHg
- Overweight and obese adults with BMI (25-40)
- Physically inactive from past 6 months assessed with pedometer. Those with step count of less than 7000 will be included
- To be able to exercise (6MWT),t hose who completed the test without any symptom
Exclusion Criteria:
- Any active systemic illness that restricts exercise
- People doing exercise on regular basis
- Any cardiopulmonary , metabolic and neurological illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Aerobic exercise training Group
|
Aerobic Exercise includes Treadmill walking At Week 1-2, intensity of 40-45% Heart rate maximum (HR max), 3 days/week, for 30 minutes At Week 3-4, intensity of 45-50% HR max, 3 days /week, for 30 minutes At Week 5-6, intensity of 50-60% HR max 3 days per week, for 30 minutes
|
|
Experimental: Resistance Exercise Training Group
|
Resistive Exercises includes (a) Leg press b) Quadriceps extension c) Bicep curl d) Hip abduction. At Week 1-2, 10 repetitions 1 set, 3 days/week, for 30 minutes At Week 3-4, 2 sets of 10 repetitions, 3 times /week for 30 minutes At week 5-6, 2 sets of 10 repetitions with 5 sec hold 3 times per week for 30 minutes |
|
Experimental: Combined Exercise Training Group
|
Combined Exercise training includes [Aerobic: Treadmill walking + Resistive Training: a) Leg press b) Quadriceps extension c) Bicep curl d) Hip abduction] Time will be reduced to 15 minutes for both trainings in respective weeks. Aerobic Exercise includes Treadmill walking At Week 1-2, intensity of 40-45% Heart rate maximum (HR max), 3 days/week, for 15 minutes At Week 3-4, intensity of 45-50% HR max, 3 days /week, for 15 minutes At Week 5-6, intensity of 50-60% HR max 3 days per week, for 15 minutes Resistive Exercises At Week 1-2, 10 repetitions 1 set, 3 days/week, for 15 minutes At Week 3-4, 2 sets of 10 repetitions, 3 times /week for 15 minutes At week 5-6, 2 sets of 10 repetitions with 5 sec hold 3 times per week for 15 minutes |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic and diastolic blood pressure
Time Frame: 6 weeks
|
Changes from the Baseline, Blood pressure is measured through sphygmomanometer
|
6 weeks
|
|
Body Mass Index (BMI)
Time Frame: 6 Week
|
Changes from the Baseline, Body mass index (BMI) will be calculated as weight (kg)/height (m2).
Below 18.5 Underweight 18.5 - 24.9 Healthy Weight 25.0 - 29.9 Overweight 30.0 and Above Obesity
|
6 Week
|
|
Change in blood lipid profile
Time Frame: 6 Week
|
Change in plasma total cholesterol, high density lipoproteins cholesterol (HDL), and low density lipoproteins cholesterol (LDL) after each treatment.
|
6 Week
|
|
Step Count
Time Frame: 6 week
|
Pedometer is a valid self-report measure of physical activity.
Pedometer is used to count the average daily steps.
Change from the baseline to 6 week will be compared.
|
6 week
|
|
Waist circumference
Time Frame: 6 week
|
Waist circumference will be measured for abdominal or central fat mass.
It is measured in cm at the middle distance between the last floating rib and the iliac crest using a retractable ergonomic measuring tape.
Change from the baseline to 6 week will be compared.
|
6 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/01083 Sidra Asghar
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Aerobic exercise training Group
-
Riphah International UniversityCompletedSpinal Cord InjuriesPakistan
-
Zhejiang UniversityKarolinska Institutet; Nanjing Sport InstituteCompleted
-
Riphah International UniversityCompletedCognitive Impairment | Type 2 DiabetesPakistan
-
VA Office of Research and DevelopmentCompleted
-
Hospital Sirio-LibanesUniversity of Nove de JulhoCompleted
-
Baltimore VA Medical CenterActive, not recruitingCancer, Breast | Cancer, Lung | Cancer, Ovarian | Cancer, ColorectalUnited States
-
Riphah International UniversityCompletedSedentary Behavior | Old Age; DebilityPakistan
-
Gazi UniversityRecruiting
-
Federal University of São PauloUnknownSystemic Lupus Erythematosus | Sleep DisordersBrazil
-
Universidad de ColimaPedro Julian Flores Moreno; Nelson Enrique Ramos CuevasNot yet recruitingHyperglycemia | Hypertriglyceridemia | Blood Pressure Disorders | Metabolic Disorders | Abdominal Obesity | HDL-DeficiencyMexico